Blood viscosity is an important determinant of local flow characteristics, which exhibits shear
thinning behavior: it decreases exponentially with increasing shear rates. Both hematocrit …

Sickle cell disease (SCD) is a group of inherited disorders caused by mutations in HBB,
which encodes haemoglobin subunit β. The incidence is estimated to be between 300,000 …

Due to the potential impact on the diagnosis and treatment of various cardiovascular
diseases, work on the rheology of blood has significantly expanded in the last decade, both …

Early diagnosis, treatment, and prevention of a vaso‐occlusive crisis (VOC) are critical to the
management of patients with sickle cell disease. It is essential to differentiate between VOC …

Sickle cell disease (SCD) is a genetic disease caused by a single mutation in the β-globin
gene, leading to the production of an abnormal hemoglobin called hemoglobin S (HbS) …

Surface passivation treatment is a widely used strategy to resolve trap‐mediated
nonradiative recombination toward high‐efficiency metal‐halide perovskite photovoltaics …

It has been long known that blood health heavily influences optimal physiological function.
Abnormalities affecting the physical properties of blood have been implicated in the …

Plasma hyperviscosity is a rare complication of both monoclonal and polyclonal disorders
associated with elevation of immunoglobulins. Asymptomatic patients with an elevation in …

Many factors in the surrounding environment have been reported to influence erythrocyte
deformability. It is likely that some influences represent reversible changes in erythrocyte …

Attachment of nanoparticles (NPs) to the surface of carrier red blood cells (RBCs) profoundly
alters their interactions with the host organism, decelerating NP clearance from the …